World malaria report. Geneva: World Health Organization; 2019
World malaria report. Geneva: World Health Organization; 2021
WHO. World Malaria Report. 20 years of global progress and challenges. Geneva: World Health Organization; 2020. p. 2020.
Google Scholar
Sehgal PN, Sharma MID, Sharma SL, Gogai S. Resistance to chloroquine in falciparum malaria in Assam state. India J Commun Dis. 1973;5:175–80.
Google Scholar
Farooq U, Mahajan RC. Drug resistance in malaria. J Vector Borne Dis. 2004;41:45–53.
Google Scholar
Anvikar AR, Arora U, Sonal GS, Mishra N, Shahi B, Savargaonkar D, et al. Antimalarial drug policy in India: past, present & future. Indian J Med Res. 2014;139:205–15.
Google Scholar
National Institute of Malaria Research (NIMR). Guidelines for diagnosis and treatment of malaria in India, 3rd ed. New Delhi: NIMR; 2014.
Bloland PB. Drug resistance in malaria. Geneva: World Health Organization; 2001.
Google Scholar
Ross LS, Dhingra SK, Mok S, Yeo T, Wicht KJ, Kümpornsin K, et al. Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine. Nat Commun. 2018;9:25–8.
Article
Google Scholar
Njiro BJ, Mutagonda RF, Chamani AT, Mwakyandile T, Sabas D, Bwire GM. Molecular surveillance of chloroquine-resistant Plasmodium falciparum in sub-Saharan African countries after withdrawal of chloroquine for treatment of uncomplicated malaria: a systematic review. J Infect Public Health. 2022;15:550–7.
Article
Google Scholar
Jiang T, Chen J, Fu H, Wu K, Yao Y, Urbano J, et al. High prevalence of Pfdhfr – Pfdhps quadruple mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Bioko Island Equatorial Guinea. Malar J. 2019;18:101.
Article
Google Scholar
Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50–5.
Article
Google Scholar
Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009;361:455–67.
Article
CAS
Google Scholar
Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM, et al. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med. 2008;359:2619–20.
Article
CAS
Google Scholar
Stokes BH, Ward KE, Fidock DA. Evidence of artemisinin-resistant malaria in Africa. N Engl J Med. 2022;386:1385–6.
Article
Google Scholar
Lal AA, Rajvanshi H, Jayswar H, Das A, Bharti P. Malaria elimination: using past and present experience to make malaria-free India by 2030. J Vector Borne Dis. 2019;56:60–5.
Article
Google Scholar
Das Sutar SK, Gupta B, Ranjit M, Kar SK, Das A. Sequence analysis of coding DNA fragments of pfcrt and pfmdr-1 genes in Plasmodium falciparum isolates from Odisha. India Mem Inst Oswaldo Cruz. 2011;106:78–84.
Article
Google Scholar
Kar NP, Chauhan K, Nanda N, Kumar A, Carlton JM, Das A. Comparative assessment on the prevalence of mutations in the Plasmodium falciparum drug-resistant genes in two different ecotypes of Odisha state. India Infect Genet Evol. 2016;41:47–55.
Article
CAS
Google Scholar
Malaria rapid diagnostic test performance: results of WHO product testing of malaria RDTs: round 8 (2016–2018). Geneva: World Health Organization; 2018.
Snounou G, Viriyakosol S, Zhu Xin Ping, Jarra W, Pinheiro L, V E do Rosario, et al. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol Biochem Parasitol. 1993;61:315–20.
Article
CAS
Google Scholar
Rozas J, Sánchez-DelBarrio JC, Messeguer X, Rozas R. DnaSP, DNA polymorphism analyses by the coalescent and other methods. Bioinformatics. 2003;19:2496–7.
Article
CAS
Google Scholar
Ahmed A, Bararia D, Vinayak S, Yameen M, Biswas S, Dev V, et al. Plasmodium falciparum isolates in India exhibit a progressive increase in mutations associated with sulfadoxine-pyrimethamine resistance. Antimicrob Agents Chemother. 2004;48:879–89.
Article
CAS
Google Scholar
Laufer MK, Takala-Harrison S, Dzinjalamala FK, Stine OC, Taylor TE, Plowe CV. Return of chloroquine-susceptible falciparum malaria in Malawi was a reexpansion of diverse susceptible parasites. J Infect Dis. 2010;202:801–8.
Article
Google Scholar
Frosch AEP, Laufer MK, Mathanga DP, Takala-Harrison S, Skarbinski J, Claassen CW, et al. Return of widespread chloroquine-sensitive Plasmodium falciparum to Malawi. J Infect Dis. 2014;210:1110–4.
Article
CAS
Google Scholar
Galatas B, Nhamussua L, Candrinho B, Mabote L, Cisteró P, Gupta H, et al. In vivo efficacy of chloroquine to clear asymptomatic infections in Mozambican adults: a randomized, placebo-controlled trial with implications for elimination strategies. Sci Rep. 2017;7:1356.
Article
Google Scholar
Balikagala B, Sakurai-Yatsushiro M, Tachibana SI, Ikeda M, Yamauchi M, Katuro OT, et al. Recovery and stable persistence of chloroquine sensitivity in Plasmodium falciparum parasites after its discontinued use in Northern Uganda. Malar J. 2020;19:76.
Article
CAS
Google Scholar
Madkhali AM, Abdulhaq AA, Atroosh WM, Ghzwani AH, Zain KA, Ghailan KY, et al. The return of chloroquine-sensitive Plasmodium falciparum parasites in Jazan region, southwestern Saudi Arabia over a decade after the adoption of artemisinin-based combination therapy: analysis of genetic mutations in the pfcrt gene. Parasitol Res. 2021;120:3771–81.
Article
Google Scholar
Ogouyèmi-Hounto A, Ndam NT, KindeGazard D, D’Almeida S, Koussihoude L, Ollo E, et al. Prevalence of the molecular marker of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in Benin seven years after the change of malaria treatment policy. Malar J. 2013;12:1147.
Google Scholar
Patgiri SJ, Sarma K, Sarmah N, Bhattacharyya N, Sarma DK, Nimolia T, et al. Characterization of drug resistance and genetic diversity of Plasmodium falciparum parasites from Tripura. Northeast India Sci Rep. 2019;9:13704.
CAS
Google Scholar
Ozarkar A, Kanyal A, Dass S, Deshpande P, Deobagkar D, Karmodiya K. Analysis of drug resistance marker genes of Plasmodium falciparum after implementation of artemisinin-based combination therapy in Pune district. India J Biosci. 2021;46:77.
Article
CAS
Google Scholar
Pathak A, Mårtensson A, Gawariker S, Sharma A, Diwan V, Purohit M, et al. Stable high frequencies of sulfadoxine-pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine-pyrimethamine in Ujjain, Madhya Pradesh. India Malar J. 2020;19:290.
Article
CAS
Google Scholar
Zomuanpuii R, Hmar CL, Lallawmzuala K, Hlimpuia L, Balabaskaran Nina P, Senthil KN. Epidemiology of malaria and chloroquine resistance in Mizoram, northeastern India, a malaria-endemic region bordering Myanmar. Malar J. 2020;19:95.
Article
CAS
Google Scholar
Awasthi G, Satya GBK, Das A. Pfcrt haplotypes and the evolutionary history of chloroquine-resistant Plasmodium falciparum. Mem Inst Oswaldo Cruz. 2012;107:129–34.
Article
Google Scholar
Das A. The distinctive features of Indian malaria parasites. Trends Parasitol. 2015;31:83–6.
Article
Google Scholar
Ranjit MR, Sahu U, Khatua CR, Mohapatra BN, Acharya AS, Kar SK. Chloroquine-resistant P. falciparum parasites and severe malaria in Orissa. Curr Sci. 2009;96:1608–11.
Google Scholar
Fairhurst RM. Understanding artemisinin-resistant malaria: what a difference a year makes. Curr Opin Infect Dis. 2015;28:417–25.
Article
CAS
Google Scholar
Das S, Saha B, Hati AK, Roy S. Evidence of artemisinin-resistant Plasmodium falciparum malaria in Eastern India. N Engl J Med. 2018;379:1962–4.
Article
Google Scholar
Arya A, Kojom Foko LP, Chaudhry S, Sharma A, Singh V. Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: a systematic review of clinical studies from two malaria endemic regions—India and sub-Saharan Africa. Int J Parasitol Drugs Drug Resist. 2021;15:43–56.
Article
CAS
Google Scholar
Chhibber-Goel J, Sharma A. Profiles of Kelch mutations in Plasmodium falciparum across South Asia and their implications for tracking drug resistance. Int J Parasitol Drugs Drug Resist. 2019;11:49–58.
Article
Google Scholar
Hemingway J, Shretta R, Wells TNC, Bell D, Djimdé AA, Achee N, et al. Tools and strategies for malaria control and elimination: what do we need to achieve a grand convergence in malaria? PLoS Biol. 2016;14:e1002380.
Article
Google Scholar
Mulenga MC, Sitali L, Ciubotariu II, Hawela MB, Hamainza B, Chipeta J, et al. Decreased prevalence of the Plasmodium falciparum Pfcrt K76T and Pfmdr1 and N86Y mutations post-chloroquine treatment withdrawal in Katete District. Eastern Zambia Malar J. 2021;20:329.
CAS
Google Scholar
Kim J, Tan YZ, Wicht KJ, Erramilli SK, Dhingra SK, Okombo J, et al. Structure and drug resistance of the Plasmodium falciparum transporter PfCRT. Nature. 2019;576:315–20.
Article
CAS
Google Scholar
Ecker A, Lehane AM, Clain J, Fidock DA. PfCRT and its role in antimalarial drug resistance. Trends Parasitol. 2012;28:504–14.
Article
CAS
Google Scholar
Xu C, Wei Q, Yin K, Sun H, Li J, Xiao T, et al. Surveillance of antimalarial resistance Pfcrt, Pfmdr1 and Pfkelch13 polymorphisms in African Plasmodium falciparum imported to Shandong Province, China. Sci Rep. 2018. https://doi.org/10.1038/s41598-018-31207-w.
Article
Google Scholar
Oguike MC, Falade CO, Shu E, Enato IG, Watila I, Baba ES, et al. Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V. Int J Parasitol Drugs Drug Resist. 2016;6:220–9.
Article
Google Scholar
McCollum AM, Poe AC, Hamel M, Huber C, Zhou Z, Shi YP, et al. Antifolate resistance in Plasmodium falciparum: multiple origins and identification of novel dhfr alleles. J Infect Dis. 2006;194:189–97.
Article
CAS
Google Scholar
Hyde JE. Mechanisms of resistance of Plasmodium falciparum to antimalarial drugs. Microbes Infect. 2002;4:165–74.
Article
CAS
Google Scholar
Ndiaye D, Daily JP, Sarr O, Ndir O, Gaye O, Mboup S, et al. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in Senegal. Trop Med Int Health. 2005;10:1176–9.
Article
CAS
Google Scholar
Roper C, Pearce R, Bredenkamp B, Gumede J, Drakeley C, Mosha F, et al. Antifolate antimalarial resistance in Southeast Africa: a population-based analysis. Lancet. 2003;361:1174–81.
Article
Google Scholar
Wang P, Lee CS, Bayoumi R, Djimde A, Doumbo O, Swedberg G, et al. Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroatesynthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins. Mol Biochem Parasitol. 1997;89:161–77.
Article
CAS
Google Scholar
Kun JFJ, Lehman LG, Lell B, Schmidt-Ott R, Kremsner PG. Low-dose treatment with sulfadoxine-pyrimethamine combinations selects for drug-resistant Plasmodium falciparum strains. Antimicrob Agents Chemother. 1999;43:2205–8.
Article
CAS
Google Scholar
Dunyo S, Ord R, Hallett R, Jawara M, Walraven G, Mesa E, et al. Randomised trial of chloroquine/sulphadoxine-pyrimethamine in Gambian children with malaria: impact against multidrug-resistant P. falciparum. PLoS Clin Trials. 2006. https://doi.org/10.1371/journal.pctr.0010014.
Article
Google Scholar
Picot S, Olliaro P, De Monbrison F, Bienvenu AL, Price RN, Ringwald P. A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria. Malar J. 2009;8:89.
Article
Google Scholar
Kublin JG, Dzinjalamala FK, Kamwendo DD, Malkin EM, Cortese JF, Martino LM, et al. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J Infect Dis. 2002;185:380–8.
Article
CAS
Google Scholar